Valeant's former Chief Financial Officer Howard Schiller has stated he won't leave the Valeant board as requested and is challenging the company's statements on his performance. In probably one of the most abrasive palace coups in corporate history, Valeant Pharmaceuticals today shed its relationship with CEO and strategy architect Michael Pearson and asked the former CFO and one-time interim CEO Howard Schiller to leave the board. In a harshly worded press release announcing the management reshuffling, Valeant lashed out at Schiller, who today is...
This content is exclusively for paying members of Hedge Fund Alpha
Insider Strategies and Letters to Shareholders from the Top Hedge Funds and Maximize Your Portfolio Growth with Hedge Fund Alpha
Don’t have an account?
Subscribe now and get 7 days free!This article is only available for Premium Members
Subscribe today and get :
Insider Strategies and Letters to Shareholders from the Top Hedge Funds
Exclusive Access to coverage of Private, Closed-Door Investor Conferences
Hedge Fund Manager Research Currently Producing 21% – 40% Returns Annually
Insider Strategies and Letters to Shareholders from the Top Hedge Funds
Exclusive Access to coverage of Private, Closed-Door Investor Conferences
Hedge Fund Manager Research Currently Producing 21% – 40% Returns Annually
